P
Protagonist Therapeutics
Biotech & Life Sciences · Newark, United States · Founded 2006 · IPO 2016
Develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies MoreLess
Protagonist Inc. is a clinical-stage biopharmaceutical company that focuses on peptide drug discovery and development. Their mission is to improve patients' lives by addressing areas of unmet need in both rare and prevalent diseases where current treatments are either limited or inadequate. They operate in the healthcare and pharmaceutical market, specifically in the area of drug discovery and development.
Their business model revolves around the discovery, development, and commercialization of peptide-based drugs. They conduct clinical trials to test the efficacy and safety of these drugs, with the ultimate goal of bringing them to market. Once a drug is approved for use, they generate revenue through its sale.
Protagonist Inc. is also committed to health equity and improving access to medicines. They ensure diverse representation in their clinical studies by actively seeking patients from various locations, age groups, and backgrounds. This includes a focus on including aging populations who are often left out of clinical studies.
In addition to their commitment to diverse patient representation, Protagonist Inc. also values diversity and inclusion within their workplace. They believe that a diverse and inclusive corporate culture is critical to their long-term success and innovation.
Keywords: Biopharmaceutical, Peptide Drug Discovery, Clinical Trials, Rare Diseases, Prevalent Diseases, Health Equity, Access to Medicines, Diverse Representation, Inclusion, Workplace Diversity.
Talent graph
Protagonist Therapeutics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Protagonist Therapeutics has talent and traffic
team presence
across markets
Patent intelligence
$63M patent portfolio · 48 active families
Where Protagonist Therapeutics concentrates vs peers
Each axis is a top-10 topic across Protagonist Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Protagonist Therapeutics
An AI-synthesized read of the highest-engagement posts about Protagonist Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Protagonist Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.










